Patient outcomes with and without tocilizumab (IMAGE)
Caption
This graph shows the outcomes over time for the COVID-19 patients on ventilators treated with and without tocilizumab at Michigan Medicine, the University of Michigan's academic medical center. The data are from an observational study that looked back at patient data from March and April, after the hospital's pharmacy guidelines early in the pandemic gave physicians information about the potential benefits and risks of prescribing the drug.
Credit
University of Michigan/Clinical Infectious Diseases
Usage Restrictions
Credit University of Michigan and Clinical Infectious Diseases journal
License
Licensed content